Medifast (MED) Change in Cash (2010 - 2026)

Medifast (MED) has 17 years of Change in Cash data on file, last reported at -$17.8 million in Q1 2026.

• Quarterly Change in Cash fell 2352.72% year-over-year to -$17.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.2 million (down 250.85% YoY) and the FY2025 annual result came in at -$1.6 million, up 53.73% from the prior year.
• Change in Cash retreated to -$17.8 million in Q1 2026, from -$10.2 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $36.1 million in Q1 2023 to a low of -$56.9 million in Q2 2022.
• A 5-year average of -$1.9 million and a median of $3.0 million in 2024 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2023 — Change in Cash soared 160.9% — and 2026, when it slumped 2352.72%.
• Tracing MED's Change in Cash over 5 years: stood at $18.0 million in 2022, then tumbled by 201.84% to -$18.3 million in 2023, then tumbled by 33.14% to -$24.4 million in 2024, then surged by 58.07% to -$10.2 million in 2025, then sank by 73.86% to -$17.8 million in 2026.
• The last three Change in Cash figures came in at -$17.8 million (Q1 2026), -$10.2 million (Q4 2025), and -$2.2 million (Q3 2025), per Business Quant data.